Ok, but besides my main point (regarding doing a cost benefit analysis), from your comments I doubt you understand herd immunity, and probably should not be attempting to teach others about it...
If the virus is too infectious you need very high rates of immunization for it to work.
https://en.wikipedia.org/wiki/Basic_reproduction_number
Most of the time those R0 values assume "well mixed populations" (any one person is just as likely to contact any other person) amongst other things, so don't take them too seriously. However, the basic idea that you don't automatically get herd immunity is simple enough. Eg, just what I found quickly on the topic:
>"Whether vaccination of healthcare personnel can lead to a herd effect reducing laboratory-confirmed influenza among patients is still inconclusive. Pooled data from a Cochrane review of 3 cluster randomized controlled trials showed no reduction of laboratory-confirmed influenza (OR 0.86, 95% CI 0.44–1.68; p = 0.66), lower respiratory tract infections, admission to hospital (OR 0.89, 95% CI 0.75–1.06), and deaths from pneumonia (OR 0.82, 95% CI 0.45–1.49) in patients when healthcare personnel were vaccinated [35]. However, given that mathematical models suggest a herd effect [36], more rigorous studies need to be conducted."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171704/